돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 4742004생성일: 2026년 10월 26일

1-Cyclopropylpiperazine

Cyclopropyl piperazine · N-cyclopropylpiperazine · 1-Cyclopropylpiperazine · Piperazine,1-cyclopropyl- · 1-Cyclopropylpiperazine >(Piperazin-1-yl)cyclopropane · 1-(Cyclopropyl Phenyl)Piperazine · 1-Cyclopropylpiperazine - [C14363] · 1-Cyclopropylpiperazine ISO 9001:2015 REACH

https://huagongshe.com/ko/chemical/4742004

1-Cyclopropylpiperazine 분자 구조식

식별자 및 물리적 특성

CAS No.20327-23-5
분자식C7H14N2
평균 분자량126.2 g/mol
단동위원소 질량126.11569845 g/mol
SMILESC1CN(C2CC2)CCN1
InChIKeyHNZJIWIXRPBFAN-UHFFFAOYSA-N
PubChem CID4742004
EC No.807-993-7
DTXSIDDTXSID20406303

화학 및 물리적 성질

XLogP0.2
극성 표면적15.3
수소 결합 공여자 수1
수소 결합 수용자 수2
회전 가능 결합 수1
무거운 원자 수9
형식 전하0
복잡도93.1
끓는 점43°C/7mm
밀도0.94
굴절률1.4804
저장 조건Keep in dark place,Sealed in dry,Room Temperature
물리적 상태투명한 액체
pKa(산도 계수)9.23±0.10(Predicted)
색상무색~연황색
InChIInChI=1S/C7H14N2/c1-2-7(1)9-5-3-8-4-6-9/h7-8H,1-6H2
InChIKeyHNZJIWIXRPBFAN-UHFFFAOYSA-N
SMILESN1(C2CC2)CCNCC1

안전 및 규제

GHS 분류DangerH302 (60%): Harmful if swallowed [Warning Acute toxicity, oral]P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 5 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesAcute Tox. 4 (60%)
운송 번호(UN)3267
관세 코드2933599590
위험 표시Xi
포장분류Ⅲ
위험 등급8

용도

용도

1-cyclopropylpiperazine is a piperazine derivative known in the literature by synonyms such as N-cyclopropylpiperazine and 4-cyclopropylpiperazine. It has been used in the preparation of some tri- and tetrasubstituted ureas with histamine H3 antagonist receptor activity, 3-amido-4- anilinoquinolines series as CSF-1R kinase inhibitors, for the synthesis of cyclopropyl amines as modulators of the histamine H3 receptor, sulfonamide compounds as cysteine protease inhibitors, N-oxides as antibacterial agents and in the treatment of the disease caused by helicobacter infection[1].